Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together

Annals of Clinical and Laboratory Science

Volumn 32, Issue 1, 2002, Pages 22-30

  Serdar, Muhittin A ^a   Oguz, Ozkan ^a   Olgun, Abdullah ^a   Seçkin, Bedrettin ^a   Ilgan, Seyfettin ^a   Hasimi, Adnan ^a   Salih, Mustafa ^a   Peker, Fuat ^a   Kutluay, Turker ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Prostate cancer; Ratio of free total prostate specific antigen; Serum total prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RELIABILITY; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 0036170605     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
2. Detection of organ-confined prostate cancer is increased through prostate specific antigen-based screening
3. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results in multicenter clinical trial of 6630 men
4. Evaluation of a low-invasive strategy for prostate cancer screening with prostate-specific antigen
5. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen
6. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adnocarcinoma of prostate
7. Serum prostate specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer
8. Clinical enzimology
9. The free to total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population
10. Molecular forms of prostate specific antigen in malignant and benign prostatic tissue: Biochemical and diagnostic implications
11. Ratio of free or complexed prostate specific antigen (PSA) to total PSA: Which ratio improves differantion between benign protatic hyperplasia and prostatic cancer?
12. Correlation of serum prostate specific antigen and quantitative immunohistochemistry
13. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
14. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
15. Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
16. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia
17. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma
18. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate
19. PSA value adjusted for transition zone volume in the diagnosis of prostate cancer
20. Comparison of three investigational assays for the free form of prostate specific antigen
21. Prostate specific antigen adjusted for transition zone volume as an indicator of prostate cancer
22. Prostate specific antigen (PSA) value adjusted for transition zone volume and free PSA (g-semino-protein)/PSA ratio in the diagnosis of prostate cancer with intermediate PSA levels
23. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves
24. Optimal predictors of prostate cancer on repeat prostate biopsy: Prospective study of 1051 men
25. Prostate specific antigen density of the transition zone: A new effective parameter for prostate cancer prediction
26. Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer
27. The use of percent free prostate specific antigen for staging clinically localized prostate cancer
28. Comparison of percent free PSA, PSA density, and age-specific PSA cut-offs for prostate cancer detection and staging
29. Serum prostate specific antigen in a community-based population of healthy men. Establishing of age-specific reference ranges
30. Interpretation of free prostate specific antigen clinical research studies for the detection on prostate cancer
31. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels